Harvinder Singh's most recent trade in Integra Lifesciences Holdings Corp was a trade of 11,965 Restricted Stock Units done . Disclosure was reported to the exchange on Oct. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Integra Lifesciences Holdings Corp | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Oct 2025 | 11,965 | 22,566 | - | - | Restricted Stock Units | |
| Integra Lifesciences Holdings Corp | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Oct 2025 | 11,965 | 25,217 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.34 per share. | 12 Oct 2025 | 3,281 | 21,936 (0%) | 0% | 13.3 | 43,769 | Common Stock |
| Integra Lifesciences Holdings Corp | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 20,133 | 20,133 | - | - | Non- Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdings Corp | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 9,508 | 13,252 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2025 | 2,356 | 4,391 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2025 | 2,356 | 34,531 | - | - | Restricted Stock Units | |
| Integra Lifesciences Holdings Corp | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.95 per share. | 11 Mar 2025 | 647 | 3,744 (0%) | 0% | 24.0 | 15,496 | Common Stock |
| Integra Lifesciences Holdings Corp | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 1,180 | 36,887 | - | - | Restricted Stock Units | |
| Integra Lifesciences Holdings Corp | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 1,180 | 2,359 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.61 per share. | 10 Mar 2025 | 324 | 2,035 (0%) | 0% | 22.6 | 7,326 | Common Stock |
| Integra Lifesciences Holdings Corp | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 16,566 | 38,067 | - | - | Restricted Stock Units | |
| Integra Lifesciences Holdings Corp | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 16,493 | 16,493 | - | - | Non- Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdings Corp | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 7,140 | 21,501 | - | - | Restricted Stock Units | |
| Integra Lifesciences Holdings Corp | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 1,179 | 14,361 | - | - | Restricted Stock Units | |
| Integra Lifesciences Holdings Corp | Harvinder Singh | EVP & PRESIDENT, INTERNATIONAL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 1,179 | 1,179 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings Corp | Harvinder Singh | Exec VP & PRES, International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 8,990 | 8,990 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdings Corp | Harvinder Singh | Exec VP & PRES, International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 3,670 | 15,635 | - | - | Restricted Stock Units | |
| Integra Lifesciences Holdings Corp | Harvinder Singh | Exec VP & PRES, International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2022 | 11,965 | 11,965 | - | - | Restricted Stock Units |